Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 2 3Phase NA 2

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Leukemia, Myeloid, Acute 82Myelodysplastic Syndromes 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 69Lymphoma, Non-Hodgkin 63Hodgkin Disease 62Leukemia 56Multiple Myeloma 52Lymphoma 46Lymphoma, Follicular 44Lymphoma, Mantle-Cell 41Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Lymphoma, Large B-Cell, Diffuse 40Lymphoma, B-Cell, Marginal Zone 39Myeloproliferative Disorders 36Burkitt Lymphoma 35Congenital Abnormalities 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 27Hematologic Neoplasms 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 22Neoplasms, Plasma Cell 22Leukemia, Myeloid, Accelerated Phase 22Anemia, Refractory, with Excess of Blasts 22Graft vs Host Disease 21Primary Myelofibrosis 20Recurrence 19Leukemia, Prolymphocytic 19Dendritic Cell Sarcoma, Interdigitating 18

Interventions

Sunitinib 64Nivolumab 54Sorafenib 38Bevacizumab 35Axitinib 35pembrolizumab 34Everolimus 30cabozantinib 29pazopanib 26aldesleukin 26Ipilimumab 23Interleukin-2 19Specimen Handling 17Magnetic Resonance Spectroscopy 17Gemcitabine 17lenvatinib 16Interferon-alpha 15Interferon alpha-2 13Radiosurgery 12Cyclophosphamide 12fludarabine phosphate 11atezolizumab 10durvalumab 8Introns 8Erlotinib Hydrochloride 8Biopsy 8temsirolimus 7avelumab 7Radiotherapy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Renal Cell × Mycophenolic Acid × Clear all
NCT00025519 2013-07-11

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Fox Chase Cancer Center

Phase 2 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00262886 2013-06-06

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

University of Rochester

Phase 2 Completed
35 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00243009 2012-05-28

Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

OHSU Knight Cancer Institute

Phase 2 Terminated
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡